Sponsor or institution
Clinical trials and research at Tianjin Anding Hospital
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Tianjin Anding Hospital that are recruiting, in China. 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Alzheimer's disease dementia: see how blood biomarkers like p-Tau217 relate to behavioral symptoms | — | Tianjin, Tianjin Municipality | Recruiting | Oct 15, 2026 |
| Targeted tACS for anhedonia in older adults with depression | — | Tianjin, Tianjin Municipality | Recruiting | Jun 10, 2026 |
| Suicide risk and learned suicide ability in people with mood disorders | — | Tianjin, Tianjin Municipality | Recruiting | Apr 13, 2026 |
| Plasma exosome microRNAs linked to cognitive problems in first-episode schizophrenia | — | Tianjin | Recruiting | Aug 24, 2025 |
| Transcranial stimulation for treatment-resistant depression with high inflammation | — | Tianjin, Tianjin Municipality | Recruiting | Feb 6, 2025 |
| Using deep transcranial magnetic stimulation to treat bipolar depression | — | Tianjin | Recruiting | Jul 29, 2024 |
All recruiting trials (6)
-
Alzheimer's disease dementia: see how blood biomarkers like p-Tau217 relate to behavioral symptoms
This is a prospective study that tests whether patients with probable Alzheimer's dementia who are negative for plasma p-Tau217 differ in behavioral symptoms from those who are positive, with follow-ups over 18 months.
-
Targeted tACS for anhedonia in older adults with depression
We’re testing personalized transcranial alternating current stimulation (tACS) to see if it improves anhedonia and depressive symptoms in people aged 60 and up with late-life depression.
-
Suicide risk and learned suicide ability in people with mood disorders
This project will try to identify which biological, psychological, social, and clinical factors relate to suicide risk and the learned ability for suicide in people aged 16–60 with mood disorders by collecting blood, urine, and questionnaire data.
-
Plasma exosome microRNAs linked to cognitive problems in first-episode schizophrenia
We will test whether patterns of plasma exosome microRNAs can explain or predict cognitive problems in people with first-episode, drug-naive schizophrenia.
-
Transcranial stimulation for treatment-resistant depression with high inflammation
This study is testing if a type of brain stimulation can help young adults with treatment-resistant depression and high inflammation feel better.
-
Using deep transcranial magnetic stimulation to treat bipolar depression
This study is testing if deep transcranial magnetic stimulation can help people with bipolar depression feel better when added to their current treatment.
Quick answers
How many clinical trials run by Tianjin Anding Hospital are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.